FOXM1 predicts disease progression in non-muscle invasive bladder cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
FOXM1 predicts disease progression in non-muscle invasive bladder cancer
Authors
Keywords
Molecular subtypes, FOXM1, Progression-free survival, Biomarker, Bladder cancer, MKI67
Journal
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-06-29
DOI
10.1007/s00432-018-2694-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The FOXO3-FOXM1 axis: A key cancer drug target and a modulator of cancer drug resistance
- (2018) Shang Yao et al. SEMINARS IN CANCER BIOLOGY
- EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
- (2017) Marko Babjuk et al. EUROPEAN UROLOGY
- Prognostic Impact of a 12-gene Progression Score in Non–muscle-invasive Bladder Cancer: A Prospective Multicentre Validation Study
- (2017) Lars Dyrskjøt et al. EUROPEAN UROLOGY
- FOXM1 predicts overall and disease specific survival in muscle-invasive urothelial carcinoma and presents a differential expression between bladder cancer subtypes
- (2017) Sebastien Rinaldetti et al. Oncotarget
- Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
- (2016) Jakob Hedegaard et al. CANCER CELL
- Recent progress with next-generation biomarkers in muscle-invasive bladder cancer
- (2016) Alberto Contreras-Sanz et al. INTERNATIONAL JOURNAL OF UROLOGY
- FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells
- (2016) Zuhal Hamurcu et al. Oncotarget
- Molecular subtypes of urothelial carcinoma are defined by specific gene regulatory systems
- (2015) Pontus Eriksson et al. BMC Medical Genomics
- Prognostic Value of FOXM1 in Patients with Malignant Solid Tumor: A Meta-Analysis and System Review
- (2015) Jun Dai et al. DISEASE MARKERS
- Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature
- (2015) Luis A. Kluth et al. EUROPEAN UROLOGY
- Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
- (2014) Woonyoung Choi et al. CANCER CELL
- Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology
- (2014) J. S. Damrauer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Incidence and predictors of understaging in patients with clinical T1 urothelial carcinoma undergoing radical cystectomy
- (2013) Jacob T. Ark et al. BJU INTERNATIONAL
- Targeting FOXM1 in cancer
- (2012) Marianna Halasi et al. BIOCHEMICAL PHARMACOLOGY
- A Molecular Taxonomy for Urothelial Carcinoma
- (2012) G. Sjodahl et al. CLINICAL CANCER RESEARCH
- Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization
- (2012) Jan Budczies et al. PLoS One
- Multiple faces of FoxM1 transcription factor
- (2011) Tanya V. Kalin et al. CELL CYCLE
- Predictors of Outcome of Non–Muscle-Invasive and Muscle-Invasive Bladder Cancer
- (2011) Ramy F. Youssef et al. TheScientificWorldJOURNAL
- Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer
- (2010) Wun-Jae Kim et al. Molecular Cancer
- FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells
- (2010) J. M.-M. Kwok et al. MOLECULAR CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search